$BFRI
Biofrontera Inc. Stock $bfri

$bfri Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022202 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$4.322M	$4.457M	$9.751M
YoY Change	-0.28%	-23.88%	105.54%
Cost Of Revenue	$2.225M	$2.554M	$5.150M
YoY Change	-2.84%	-17.82%	100.31%
Gross Profit	$2.097M	$1.903M	$4.601M
YoY Change	2.59%	-30.72%	111.73%
Gross Profit Margin	48.52%	42.7%	47.18%
Selling, General & Admin	$7.765M	$9.669M	$7.711M
YoY Change	-54.99%	74.15%	56.66%
% of Gross Profit	370.29%	508.09%	167.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$131.0K	$26.00K	$131.0K
YoY Change	-2.24%	-21.21%	-5.07%
% of Gross Profit	6.25%	1.37%	2.85%
Operating Expenses	$7.961M	$10.67M	$7.711M
YoY Change	-55.65%	11.81%	42.27%
Operating Profit	-$3.639M	-$6.212M	-$3.110M
YoY Change	-77.12%	68.48%	-4.22%
Interest Expense	$89.00K	$38.00K	-$33.00K
YoY Change	-203.49%	-55.29%	-60.71%
% of Operating Profit
Other Income/Expense, Net	$1.074M	$5.362M	$8.734M
YoY Change	480.54%	7560.0%	10955.7%
Pretax Income	-$2.565M	-$850.0K	$5.591M
YoY Change	-83.97%	-76.5%	-258.25%
Income Tax	$1.000K		$30.00K
% Of Pretax Income			0.54%
Net Earnings	-$2.566M	-$850.0K	$5.561M
YoY Change	-83.97%	-76.78%	-257.36%
Net Earnings / Revenue	-59.37%	-19.07%	57.03%
Basic Earnings Per Share	-$0.11	-$0.05	$0.33
Diluted Earnings Per Share	-$0.11	-$0.05	$324.6K
COMMON SHARES
Basic Shares Outstanding	23.55M shares	18.82M shares	17.10M shares
Diluted Shares Outstanding	22.73M shares	18.82M shares	17.13M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.60M	$32.04M	$22.56M
YoY Change	1402.61%	909.8%	374.06%
Cash & Equivalents	$27.50M	$31.91M	$22.43M
Short-Term Investments	$85.00K	$128.0K	$128.0K
Other Short-Term Assets	$721.0K	$1.086M	$1.245M
YoY Change	-11.53%	2.94%	23.39%
Inventory	$12.09M	$8.808M	$4.872M
Prepaid Expenses	$460.0K	$599.0K
Receivables	$5.065M	$5.046M	$13.86M
Other Receivables	$3.017M	$0.00	$0.00
Total Short-Term Assets	$48.49M	$46.98M	$42.53M
YoY Change	378.38%	269.06%	164.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$224.0K	$248.0K	$245.0K
YoY Change	-22.49%	-21.02%	-26.65%
Goodwill
YoY Change
Intangibles	$3.136M	$3.241M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$393.0K	$343.0K	$268.0K
YoY Change	-71.38%	-65.42%	-55.03%
Total Long-Term Assets	$6.566M	$6.645M	$6.671M
YoY Change	25.86%	33.84%	42.12%
TOTAL ASSETS
Total Short-Term Assets	$48.49M	$46.98M	$42.53M
Total Long-Term Assets	$6.566M	$6.645M	$6.671M
Total Assets	$55.06M	$53.63M	$49.20M
YoY Change	258.6%	203.06%	136.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$253.0K	$931.0K	$571.0K
YoY Change	-87.53%	-0.11%	-29.94%
Accrued Expenses	$9.442M	$9.413M	$7.819M
YoY Change	6.85%	304.86%	263.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.14M	$14.88M	$12.36M
YoY Change	51.83%	269.04%	205.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.646M	$5.650M	$19.43M
YoY Change	-73.67%	-62.41%	34.42%
Total Long-Term Liabilities	$5.646M	$5.650M	$19.43M
YoY Change	-73.67%	-62.41%	34.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.14M	$14.88M	$12.36M
Total Long-Term Liabilities	$5.646M	$5.650M	$19.43M
Total Liabilities	$32.46M	$36.39M	$31.79M
YoY Change	-0.82%	90.92%	71.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.70M	-$74.20M
YoY Change
Common Stock	$23.00K	$19.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.60M	$17.23M	$17.42M
YoY Change
Total Liabilities & Shareholders Equity	$55.06M	$53.63M	$49.20M
YoY Change	258.6%	203.06%	136.59%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.566M	-$850.0K	$5.561M
YoY Change	-83.97%	-76.78%	-257.36%
Depreciation, Depletion And Amortization	$131.0K	$26.00K	$131.0K
YoY Change	-2.24%	-21.21%	-5.07%
Cash From Operating Activities	-$5.941M	$125.0K	-$2.112M
YoY Change	388.17%	-111.74%	-38.66%
INVESTING ACTIVITIES
Capital Expenditures	-$1.000K	-$31.00K	-$5.000K
YoY Change	-200.0%	933.33%
Acquisitions
YoY Change
Other Investing Activities	-$3.033M
YoY Change
Cash From Investing Activities	-$3.034M	-$31.00K	-$5.000K
YoY Change	-303500.0%	933.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.630M	9.391M
YoY Change	-3926.45%	-1916.44%
NET CHANGE
Cash From Operating Activities	-5.941M	125.0K	-2.112M
Cash From Investing Activities	-3.034M	-31.00K	-5.000K
Cash From Financing Activities	4.630M	9.391M
Net Change In Cash	-4.345M	9.485M	-2.117M
YoY Change	224.98%	-698.42%
FREE CASH FLOW
Cash From Operating Activities	-$5.941M	$125.0K	-$2.112M
Capital Expenditures	-$1.000K	-$31.00K	-$5.000K
Free Cash Flow	-$5.940M	$156.0K	-$2.107M
YoY Change	387.68%	-114.69%	-38.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4458000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1214000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4987000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001858685
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges		usd
	us-gaap	Restructuring Charges RestructuringCharges		usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	46981000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	BFRI	Receivable For Common Stock Warrants Proceeds ReceivableForCommonStockWarrantsProceeds		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2021Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	46421000	usd
CY2021Q2	us-gaap	Interest Income Related Party InterestIncomeRelatedParty		usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty		usd
CY2022Q2	BFRI	Reimbursed Costs ReimbursedCosts		usd
	BFRI	Reimbursed Costs ReimbursedCosts		usd
CY2022Q2	BFRI	Stock Options And Restricted Stock Units StockOptionsAndRestrictedStockUnits		shares
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40943
	dei	Entity Registrant Name EntityRegistrantName	Biofrontera Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3765675
	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Presential Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 330
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	City Area Code CityAreaCode	(781)
	dei	Local Phone Number LocalPhoneNumber	245-1325
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23550960	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31913000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24545000	usd
CY2022Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	2001000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3784000	usd
CY2022Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	3045000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	8647000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	8808000	usd
CY2022Q2	us-gaap	Accounts Receivable Related Parties Noncurrent AccountsReceivableRelatedPartiesNoncurrent	2813000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Noncurrent AccountsReceivableRelatedPartiesNoncurrent	2813000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	267000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3241000	usd
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3450000	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	343000	usd
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Other Assets OtherAssets	268000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53219000	usd
CY2022Q2	us-gaap	Assets Assets	53626000	usd
CY2021Q4	us-gaap	Assets Assets	53219000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	931000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	658000	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1290000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	282000	usd
CY2022Q2	BFRI	Acquisition Contract Liabilities Net Current AcquisitionContractLiabilitiesNetCurrent	3242000	usd
CY2021Q4	BFRI	Acquisition Contract Liabilities Net Current AcquisitionContractLiabilitiesNetCurrent	3242000	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9413000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9654000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14876000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13836000	usd
CY2022Q2	BFRI	Acquisition Contract Liabilities Net Noncurrent AcquisitionContractLiabilitiesNetNoncurrent	7821000	usd
CY2021Q4	BFRI	Acquisition Contract Liabilities Net Noncurrent AcquisitionContractLiabilitiesNetNoncurrent	9542000	usd
CY2022Q2	BFRI	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	8046000	usd
CY2021Q4	BFRI	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	12854000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5650000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5649000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	36393000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	41881000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19011438	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19011438	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17104749	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17104749	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91382000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90200000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74168000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78879000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17233000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	11338000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53626000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4457000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5855000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14208000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10599000	usd
CY2022Q2	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	2402000	usd
CY2021Q2	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	2973000	usd
	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	7377000	usd
	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	5381000	usd
CY2022Q2	BFRI	Cost Of Revenues CostOfRevenues	152000	usd
CY2021Q2	BFRI	Cost Of Revenues CostOfRevenues	135000	usd
	BFRI	Cost Of Revenues CostOfRevenues	327000	usd
	BFRI	Cost Of Revenues CostOfRevenues	298000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9669000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5552000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17285000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10310000	usd
CY2022Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	346000	usd
CY2021Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	196000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	441000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	360000	usd
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	186000	usd
	us-gaap	Restructuring Charges RestructuringCharges	467000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1900000	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	500000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1900000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	998000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	10669000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	9542000	usd
	us-gaap	Operating Expenses OperatingExpenses	23530000	usd
	us-gaap	Operating Expenses OperatingExpenses	17814000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6212000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3687000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9322000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7215000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5371000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14082000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-38000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-85000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-71000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-169000	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	29000	usd
CY2021Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	155000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	52000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	234000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5362000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	70000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14063000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	65000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-850000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3617000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4741000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7150000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-850000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3661000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4711000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7195000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18823497	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17968870	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18823497	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18044174	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17416000	usd
CY2022Q2	BFRI	Stock Issued During Period Value Private Placement Offering StockIssuedDuringPeriodValuePrivatePlacementOffering	116000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	551000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-850000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17233000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	11338000	usd
	BFRI	Stock Issued During Period Value Private Placement Offering StockIssuedDuringPeriodValuePrivatePlacementOffering	116000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1068000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4711000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17233000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	2294000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3661000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1367000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5828000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7195000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1367000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4711000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7195000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1987000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4508000	usd
	us-gaap	Depreciation Depreciation	54000	usd
	us-gaap	Depreciation Depreciation	66000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	209000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	209000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1900000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-998000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14082000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1068000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	100000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	34000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	133000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	33000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	179000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	179000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1650000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1499000	usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	-5602000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-3698000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	114000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4449000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-330000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	1280000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-699000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-240000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	152000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	517000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9391000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9391000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-517000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7368000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5028000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24742000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8277000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32110000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3249000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31900000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24500000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9300000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7200000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2000000.0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4500000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74200000	usd
CY2022Q2	BFRI	Working Capital Payments WorkingCapitalPayments	7300000	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5600000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zzDPaF1AbKKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zHa3lS3NEnzi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions by management that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities, as reported on the balance sheet date, and the reported amounts of revenues and expenses arising during the reporting period. The main areas in which assumptions, estimates and the exercising of judgment are appropriate relate to, valuation allowances for receivables and inventory, valuation of contingent consideration and warrant liabilities, valuation of intangible and other long-lived assets, product sales allowances and reserves, share-based payments and income taxes including deferred tax assets and liabilities. Estimates are based on historical experience and other assumptions that are considered appropriate in the circumstances. They are continuously reviewed but may vary from the actual values.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	4300000	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	6200000	usd
CY2022Q2	BFRI	Startup Cost Financing StartupCostFinancing	7300000	usd
CY2021Q4	BFRI	Startup Cost Financing StartupCostFinancing	7300000	usd
CY2022Q2	BFRI	Contract Asset ContractAsset	-537000	usd
CY2021Q4	BFRI	Contract Asset ContractAsset	-716000	usd
CY2022Q2	BFRI	Acquisition Contract Liabilities Net AcquisitionContractLiabilitiesNet	11063000	usd
CY2021Q4	BFRI	Acquisition Contract Liabilities Net AcquisitionContractLiabilitiesNet	12784000	usd
CY2020Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	7602000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	998000	usd
CY2021Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	8600000	usd
CY2021Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	6200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1900000	usd
CY2022Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	4300000	usd
CY2021Q4	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	12854000	usd
	BFRI	Fair Value Warrant Issuance Of New Derivative Liabilities FairValueWarrantIssuanceOfNewDerivativeLiabilities	9274000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14082000	usd
CY2022Q2	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	8046000	usd
CY2020Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	327000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	203000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	371000	usd
CY2021Q2	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	159000	usd
CY2021Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	246000	usd
CY2021Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	246000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	517000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	440000	usd
CY2022Q2	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	331000	usd
CY2022Q2	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	331000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	126000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18000	usd
CY2022Q2	BFRI	Legal Settlements Receivable Percentage LegalSettlementsReceivablePercentage	0.50	pure
CY2022Q2	us-gaap	Other Receivables OtherReceivables	300000	usd
CY2021Q4	BFRI	Receivable For Common Stock Warrants Proceeds ReceivableForCommonStockWarrantsProceeds	3258000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	599000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	824000	usd
CY2022Q2	us-gaap	Deposit Assets DepositAssets	128000	usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets	149000	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	487000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	756000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1214000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4987000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	708000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	673000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	460000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	406000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	267000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	26000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	33000	usd
	us-gaap	Depreciation Depreciation	54000	usd
	us-gaap	Depreciation Depreciation	66000	usd
CY2022Q2	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
CY2021Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1359000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1150000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3241000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3450000	usd
CY2022Q2	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2021Q4	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2302000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2384000	usd
CY2022Q2	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31913000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24545000	usd
CY2022Q2	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	47000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	47000	usd
CY2022Q2	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	150000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	150000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32110000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24742000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	659000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	570000	usd
CY2022Q2	BFRI	Accrued Product Revenue Allowances And Reserves AccruedProductRevenueAllowancesAndReserves	331000	usd
CY2021Q4	BFRI	Accrued Product Revenue Allowances And Reserves AccruedProductRevenueAllowancesAndReserves	246000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	496000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	829000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9413000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9654000	usd
CY2022Q2	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2021Q4	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2022Q2	BFRI	Other Liability Noncurrent OtherLiabilityNoncurrent	25000	usd
CY2021Q4	BFRI	Other Liability Noncurrent OtherLiabilityNoncurrent	24000	usd
CY2022Q2	us-gaap	Other Liabilities OtherLiabilities	5650000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	5649000	usd
CY2022Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	0	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	0	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	500000	usd
CY2022Q2	BFRI	Legal Settlements Receivable Percentage LegalSettlementsReceivablePercentage	0.50	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613614000	shares
CY2022Q2	us-gaap	Restructuring Costs RestructuringCosts	0	usd
	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2021Q2	us-gaap	Restructuring Costs RestructuringCosts	500000	usd
	us-gaap	Restructuring Costs RestructuringCosts	500000	usd
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9400000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1081812000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.62
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	63946000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.77
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1631480000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y8M23D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7332000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.61
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y10M17D
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2700000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	343512	shares
CY2022Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	3000	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	7000	usd
CY2022Q2	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	89000	usd
CY2021Q2	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	89000	usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	179000	usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	179000	usd
CY2022Q2	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	53000	usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	110000	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	1000	usd
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther	4000	usd
	us-gaap	Interest Income Other InterestIncomeOther	5000	usd
	us-gaap	Interest Income Other InterestIncomeOther	10000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	38000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	85000	usd
	us-gaap	Interest Expense InterestExpense	71000	usd
	us-gaap	Interest Expense InterestExpense	169000	usd
CY2021Q2	BFRI	Reimbursed Costs ReimbursedCosts	185000	usd
	BFRI	Reimbursed Costs ReimbursedCosts	284000	usd
CY2022Q2	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	29000	usd
CY2021Q2	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	-30000	usd
	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	52000	usd
	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	-50000	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	29000	usd
CY2021Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	155000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	52000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	234000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-850000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3661000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4711000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7195000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18823497	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17968870	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
	BFRI	Stock Options And Restricted Stock Units StockOptionsAndRestrictedStockUnits	75304	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18823497	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18044174	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2022Q2	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	414000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	609000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	474000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	352000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1849000	usd
CY2021Q4	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	the Company entered into a settlement and release agreement with respect to a lawsuit filed March 23, 2018
CY2021Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	22500000	usd
CY2021Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	11250000	usd
	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	aggregate settlement amount, plus interest accrued at a rate equal to the weekly average one-year constant maturity Treasury yield and agreed to pay in three annual installments.
CY2022Q2	BFRI	Legal Settlement Liability LegalSettlementLiability	11300000	usd
CY2022Q2	us-gaap	Loss Contingency Receivable LossContingencyReceivable	5600000	usd
	us-gaap	Description Of Nature And Effect Of Significant Changes During Period Affecting Comparability DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability	The Company matches 50% of employee contributions up to a maximum of 6% of employees’ salary
CY2022Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	47000	usd
CY2021Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	67000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd

Files In Submission

Name	View Source	Status
0001493152-22-022202-index-headers.html	Edgar Link	pending
0001493152-22-022202-index.html	Edgar Link	pending
0001493152-22-022202.txt	Edgar Link	pending
0001493152-22-022202-xbrl.zip	Edgar Link	pending
bfri-20220630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
bfri-20220630_def.xml	Edgar Link	unprocessable
bfri-20220630_cal.xml	Edgar Link	unprocessable
bfri-20220630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bfri-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BFRI
Biofrontera Inc. Stock $bfri

2022 Q3 Form 10-Q Financial Statement

#000149315222022202 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFRI Biofrontera Inc. Stock $bfri

2022 Q3 Form 10-Q Financial Statement

#000149315222022202 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFRI
Biofrontera Inc. Stock $bfri